Browsing by Author Van Cutsem, E

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2012Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialClarke, Stephen; Cartwright, Thomas; Cunningham, David; De Gramont, A.; et al, Various; Hecht, J; Im, Seock-Ah; Moore, Malcolm; Rivera, Fernando; Schmoll, Hans-Joachim; Tabernero, Josep; Van Cutsem, E; Concord Clinical School: MedicineBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial, Lancet Oncology, vol.13, 12, 2012,pp 1225-1233
2012Management of advanced gastric cancerPavlakis, Nick; Price, Timothy; Segelov, Eva; Tebbutt, Niall; Kang, Yoon-Koo; Karapetis, Christos; Shah, Manish; Shapiro, Jeremy; Van Cutsem, E; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreManagement of advanced gastric cancer, Expert Review of Gastroenterology and Hepatology, vol.6, 2, 2012,pp 199-209
2008A phase lb dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patientsBeale, Philip; Clarke, Stephen; Brennscheidt, U; Bugat, R; Delord, J P; Fettner, S H; Feyereislova, Andrea; Rakhit, A; Van Cutsem, E; Verslype, C; Central Clinical School: Medicine; Northern Clinical School: Kolling InstituteA phase lb dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients, Annals of Oncology, vol.19, 2, 2008,pp 332-339